Assessment of Patients With Multiple Sclerosis (MS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00001156|
Recruitment Status : Completed
First Posted : November 4, 1999
Last Update Posted : July 2, 2017
Multiple sclerosis (MS) is a disease of the nervous system. The exact cause of MS is unknown, but it is believed to be an autoimmune condition. Autoimmune conditions are diseases that cause the body's immune system and natural defenses to attack healthy cells. In the case of MS, the immune system begins attacking myelin, the cells that make up the sheath covering nerves. Without myelin, nerves are unable to transmit signals effectively and symptoms occur.
This study is directed toward a better understanding of the cause of Multiple Sclerosis (MS). Researchers will evaluate patients with a tentative diagnosis of MS or other neurological diseases possibly caused by a immunological reaction. Patients will undergo a series of three MRIs, taken once a month for three months and submit blood samples for immunological studies.
|Condition or disease|
|Herpesviridae Infection HTLV-I Infection Multiple Sclerosis Tropical Spastic Paraparesis Vasculitis|
|Study Type :||Observational|
|Actual Enrollment :||1388 participants|
|Official Title:||Combined Clinical, Immunological and Virological Assessment of Patients With Multiple Sclerosis (MS)|
|Study Start Date :||January 23, 1976|
|Estimated Study Completion Date :||February 1, 2010|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00001156
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|